Condition

Anxiety Disorder

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 48 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials48

Recruiting2

Common interventions25

Lead sponsors shown15

Clinical trials

48 shown

Identification and Molecular Characterisation of Urban-environmental Stress Patterns Affecting Mental IllnessNCT07571226 · 2026-04-10

Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Pharmacological ManipulationNCT05232032 · 2025-02-01

Cognition and Affective Research in ChinaNCT07833267 · 2026-10-01

NOT_YET_RECRUITING

Music Therapy Advocacy Recording Intervention (MTAR) on Internalized StigmaNCT05723328 · 2023-04-25

The Relationship Between Emotion Regulation and Psychiatric Disorder in YouthNCT06271954 · 2023-03-27

Clinical Study of Biomarkers of Stress Resilience: Role of ELK1 and GPR56NCT05488418 · 2022-09-01

Reducing Stigma Among Healthcare Providers (RESHAPE-cRCT)NCT04282915 · 2022-02-22

Risk of Mental Health Conditions in Children and Young Adults With Inflammatory Bowel Disease and Influence on HealthNCT05206734 · 2022-01-05

Tapering Off AntidepressantsNCT02661828 · 2016-01-01

Ketamine Infusion for Adolescent Depression and AnxietyNCT02579928 · 2015-10-01

Supported Employment in Patient Aligned Care TeamsNCT02400736 · 2015-08-03

Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family CaregiversNCT02349412 · 2015-06-25

Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast CancerNCT02203552 · 2015-06-23

Improve: Integrating Emotion Focused Components Into Psychological TherapyNCT02822443 · 2015-04-01

The Process Outcome Mindfulness Effects in Trainees (PrOMET)-StudyNCT02270073 · 2014-10-01

Effect of Lactobacillus Plantarum 299v Supplementation on Major Depression TreatmentNCT02469545 · 2014-06-01

A Pilot, Proof-of-concept Cohort Study of the Prevalence of Comorbid Mental Illness and Substance AbuseNCT02476877 · 2014-06-01

Interactive Gentle Yoga in Improving Quality of Life in Patients With Stage I-III Breast Cancer Undergoing Radiation TherapyNCT02023008 · 2014-05-01

PET Imaging of Brain mGluR1 Receptors Using [18F]FIMXNCT02230592 · 2013-11-08

Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in GhanaNCT02593734 · 2013-07-01

Cognitive Behavioral Therapy in Treating Anxiety in Patients With Stage IV Non-Small Cell Lung Cancer and Their CaregiversNCT01729689 · 2012-11-01

Study of Donepezil in Female Breast Cancer Survivors With Cognitive DysfunctionNCT01466270 · 2012-07-01

Depression Agency-Based CollaborationNCT01566318 · 2012-03-01

S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer SurvivorsNCT01453452 · 2012-03-01

Multimodal Assessment of Neurobiological Markers for Psychiatric DisordersNCT01477203 · 2011-11-01

The Effect of IPS-MA- A Modified Early Supported Employment Intervention for Individuals With Mood or Anxiety DisordersNCT01721824 · 2011-10-01

A Working Memory Training to Decrease Rumination in Depressed and Anxious IndividualsNCT02119975 · 2011-08-01

Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer SurvivorsNCT01929720 · 2011-08-01

Tackling Depression and Anxiety: A Working Memory InterventionNCT02119923 · 2011-04-01

Imaging Serotonin 5HT1A Receptors in Patients With Major Depressive DisorderNCT01313403 · 2011-02-10

Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast CancerNCT01764789 · 2010-10-01

PET Whole Body Distribution Studies Using [11C]CUMINCT01132872 · 2010-04-30

Study of How Caregivers Help Patients Cope With Respiratory and Other Symptoms Caused by Lung CancerNCT00979888 · 2009-07-01

Cranial Stimulation for Chemotherapy Symptoms in Breast CancerNCT00902330 · 2009-04-01

Educational Counseling in Improving Communication and Quality of Life in Spouses and Breast Cancer PatientsNCT01723943 · 2009-03-01

Photobiomodulation to Alter Cerebral Blood Flow and to Affect the Emotional Status of Patients With Major DepressionNCT00961454 · 2009-01-01

Hypnosis in Reducing Pain and Other Side Effects in Women Undergoing Surgery for Breast CancerNCT00748267 · 2008-08-01

Mindful Movement Program in Improving Quality of Life in Older Female Breast Cancer SurvivorsNCT00903474 · 2008-08-01

Acupuncture in Reducing Muscle and Bone Symptoms in Women Receiving Letrozole, Exemestane, or Anastrozole for Stage 0, Stage I, Stage II, or Stage III Breast CancerNCT00641303 · 2008-05-01

Measuring Stress in Women With Newly Diagnosed Stage I, Stage II, or Stage III Breast Cancer or Ductal Carcinoma In Situ of the BreastNCT00665782 · 2008-03-01

Acupuncture or Self-Acupuncture in Managing Cancer-Related Fatigue in Women Who Have Received Chemotherapy for Stage I, Stage II, or Stage IIIA Breast CancerNCT00957112 · 2007-10-01

Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial TherapyNCT00896467 · 2007-09-01

Thinking Skills for Work in Severe Mental IllnessNCT01926613 · 2006-04-01

Study of Anxiety and Avoidance of Others in Patients Previously Treated for Head and Neck CancerNCT00483639 · 2003-11-01

Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerNCT00005850 · 2001-08-01

Gabapentin For the Control of Hot Flashes in Women With Breast CancerNCT00022074 · 2001-07-01

New Drugs in the Treatment of Mood DisordersNCT00001482 · 1995-05-01

Neuropsychological Evaluation of Psychiatric and Neurological PatientsNCT00001192 · 1983-10-18

Common interventions

Leading sponsors

National Institute of Mental Health (NIMH)5 Ohio State University Comprehensive Cancer Center3 Wake Forest University Health Sciences3 Alliance for Clinical Trials in Oncology2 City of Hope Medical Center2 Erasmus Medical Center2 University of Manchester2 Advanced Clinical Laboratory Solutions, Inc.1 Amager Hospital1 Assistance Publique Hopitaux De Marseille1 Centre Oscar Lambret1 Chang Gung Memorial Hospital1 Dartmouth-Hitchcock Medical Center1 Emory University1 Gary Morrow1

Trial status mix

COMPLETED37

TERMINATED4

UNKNOWN3

RECRUITING2

NOT_YET_RECRUITING1

WITHDRAWN1

Phase mix

NA23

PHASE27

PHASE33

PHASE43

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.